Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides
Clinical trial NCT02900027 · COMPLETED
Trial details
- NCT number
- NCT02900027
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-04-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.